Effects of Attention Training on Children

May 4, 2020 updated by: Ru-Lan Hsieh, Taipei Medical University

Therapeutic Effects of Interactive Attention Training on Children With Attention Deficit Hyperactivity Disorder

Using a double-blind, randomized controlled design to investigate the therapeutic effects of interactive attention training for children with Attention Deficit Hyperactivity Disorder who are receiving conventional rehabilitation programs due to developmental delay.

Study Overview

Detailed Description

A total of 30 children with Attention Deficit Hyperactivity Disorder conducting conventional rehabilitation programs well be enrolled.

The children are randomized into two groups, including study group with conventional rehabilitation programs and interactive attention training: 2 times per week, 15 min per session, with a total of 24 sessions in 3 months; and control group with conventional rehabilitation programs without interactive attention training.

Therapeutic effects, including working memory, attention, functional performance, physical function, health-related quality of life will be evaluated at baseline, and 3 months and 6 months after the intervention.

The evaluator and children will be blinded to the group's allocation during the whole course of the intervention.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 111-01
        • Shin Kong Wu Ho-Su Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 8 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children with a diagnosis of Attention Deficit Hyperactivity Disorder with developmental delay, under regular conventional rehabilitation programs, Intelligence quotient 70 or greater

Exclusion Criteria:

  • age less than 4 or greater than 8 of children diagnosed with Attention Deficit Hyperactivity Disorder with developmental delay, under regular conventional rehabilitation programs, Intelligence quotient less than 70

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Study group
3 months of interactive attention training programs, 2 times per week, 15 min per session, a total of 24 sessions, with conventional rehabilitation programs
using the interactive attention training system to children with Attention Deficit Hyperactivity Disorder
No Intervention: Control group
3 months of conventional rehabilitation programs without interactive attention training programs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes of symptoms of attention deficit hyperactivity disorder
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a better outcome
score assessed by Swanson, Nolan and Pelham questionnaire
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a better outcome

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes of sensory integration
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Sensory Profile
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of visual motor integration
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Beery-Buktenica Visual Motor Integration Test
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of intelligence
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Wechsler Intelligence Scale for Children
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of functional performance
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Pediatric Outcome Data Collection Instrument
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of health-related quality of life
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
score assessed by Pediatric Quality of Life Inventory
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of family impact
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
Child Health Questionnaire, parent form 28
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of walking speed
Time Frame: time change from baseline to 3 months of treatment, and 3 months after treatment
walking speed
time change from baseline to 3 months of treatment, and 3 months after treatment
changes of chair climbing speed
Time Frame: time change from baseline to 3 months of treatment, and 3 months after treatment
stairs climbing speed
time change from baseline to 3 months of treatment, and 3 months after treatment
changes of balance
Time Frame: time change from baseline to 3 months of treatment, and 3 months after treatment
one leg standing time
time change from baseline to 3 months of treatment, and 3 months after treatment
changes of coordination
Time Frame: score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
Berg Balance Scale
score change from baseline to 3 months of treatment, and 3 months after treatment, lower scores mean a worse outcome
changes of balance and coordination
Time Frame: time change from baseline to 3 months of treatment, and 3 months after treatment
timed up and go test
time change from baseline to 3 months of treatment, and 3 months after treatment
changes of physical performance
Time Frame: time change from baseline to 3 months of treatment, and 3 months after treatment
5 time sit to stand test
time change from baseline to 3 months of treatment, and 3 months after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ru-Lan Ru-Lan, MD, Shin Kong Wu Ho-Su Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2020

Primary Completion (Anticipated)

December 31, 2020

Study Completion (Anticipated)

December 31, 2020

Study Registration Dates

First Submitted

April 29, 2020

First Submitted That Met QC Criteria

May 4, 2020

First Posted (Actual)

May 5, 2020

Study Record Updates

Last Update Posted (Actual)

May 5, 2020

Last Update Submitted That Met QC Criteria

May 4, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Hyperactivity Disorder

Clinical Trials on using interactive attention training system

Subscribe